Sunflower Pharmaceuticals Group Co Ltd (002737) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.028x

Based on the latest financial reports, Sunflower Pharmaceuticals Group Co Ltd (002737) has a cash flow conversion efficiency ratio of -0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-117.97 Million ≈ $-17.26 Million USD) by net assets (CN¥4.23 Billion ≈ $619.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Sunflower Pharmaceuticals Group Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Sunflower Pharmaceuticals Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Sunflower Pharmaceuticals Group Co Ltd (002737) total liabilities for a breakdown of total debt and financial obligations.

Sunflower Pharmaceuticals Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sunflower Pharmaceuticals Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Runda Med Tech Co SHG:603108	0.027x
SANOFI CONS HEALTHC IND L NSE:SANOFICONR	N/A
Shenzhen Hui Chuang Da Technology Co.Ltd SHE:300909	0.012x
Da An Gene Co Ltd of Sun Yat-Sen University SHE:002030	0.014x
LianChuang Electronic Technology Co Ltd SHE:002036	0.001x
Kingsgate Consolidated Ltd AU:KCN	0.153x
Anhui Guofeng Plastic Industry Co Ltd SHE:000859	-0.005x
Jiangxi Guoguang Commercial Chains Co Ltd SHG:605188	0.036x

Annual Cash Flow Conversion Efficiency for Sunflower Pharmaceuticals Group Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Sunflower Pharmaceuticals Group Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.59 Billion ≈ $671.66 Million	CN¥-307.48 Million ≈ $-44.99 Million	-0.067x	-136.31%
2023-12-31	CN¥5.00 Billion ≈ $732.34 Million	CN¥923.30 Million ≈ $135.11 Million	0.184x	-58.45%
2022-12-31	CN¥4.44 Billion ≈ $649.53 Million	CN¥1.97 Billion ≈ $288.39 Million	0.444x	+101.93%
2021-12-31	CN¥3.94 Billion ≈ $575.83 Million	CN¥865.23 Million ≈ $126.61 Million	0.220x	-36.27%
2020-12-31	CN¥3.39 Billion ≈ $496.17 Million	CN¥1.17 Billion ≈ $171.19 Million	0.345x	+20.58%
2019-12-31	CN¥3.43 Billion ≈ $501.87 Million	CN¥981.33 Million ≈ $143.60 Million	0.286x	+13.53%
2018-12-31	CN¥3.44 Billion ≈ $502.93 Million	CN¥866.21 Million ≈ $126.75 Million	0.252x	+42.60%
2017-12-31	CN¥3.16 Billion ≈ $462.64 Million	CN¥558.77 Million ≈ $81.77 Million	0.177x	+45.25%
2016-12-31	CN¥2.80 Billion ≈ $410.38 Million	CN¥341.23 Million ≈ $49.93 Million	0.122x	+152.41%
2015-12-31	CN¥2.61 Billion ≈ $381.99 Million	CN¥125.84 Million ≈ $18.41 Million	0.048x	-72.75%
2014-12-31	CN¥2.28 Billion ≈ $333.59 Million	CN¥403.23 Million ≈ $59.00 Million	0.177x	-47.60%
2013-12-31	CN¥869.02 Million ≈ $127.17 Million	CN¥293.34 Million ≈ $42.93 Million	0.338x	-21.79%
2012-12-31	CN¥758.39 Million ≈ $110.98 Million	CN¥327.31 Million ≈ $47.90 Million	0.432x	-8.95%
2011-12-31	CN¥543.47 Million ≈ $79.53 Million	CN¥257.60 Million ≈ $37.70 Million	0.474x	--

About Sunflower Pharmaceuticals Group Co Ltd

SHE:002737 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.19 Billion

CN¥8.11 Billion CNY

Market Cap Rank

#8376 Global

#2154 in China

Share Price

CN¥13.88

Change (1 day)

+5.95%

52-Week Range

CN¥11.89 - CN¥16.74

All Time High

CN¥28.79